Generation Bio Funding: $125M Raised, IPO

Generation Bio has raised $125M in total funding. Latest round: IPO. Backed by Casdin, Atlas Venture.

Generation Bio funding overview

Generation Bio has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO. Investors on record include Casdin, Atlas Venture. 2 distinct backers are named across the disclosed rounds.

Generation Bio at a glance

Total raised
$125M
Latest round
IPO
Notable investors
Casdin, Atlas Venture

Frequently asked about Generation Bio funding

How much has Generation Bio raised?
Generation Bio has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Generation Bio?
Casdin, Atlas Venture are named among the investors backing Generation Bio.
What was the latest Generation Bio funding round?
The most recent disclosed round is an IPO.
Where is Generation Bio based?
No headquarters location is disclosed for Generation Bio.

Generation Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Companies related to Generation Bio (30)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades